Background illustration for clinical trials search

Paid Clinical Trials Louisville

Discover 503 paid clinical trials in Louisville, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps

for
Chronic Rhinosinusitis Without Nasal Polyps
Location: Louisville KY, Springfield IL, Columbia MO,
Sponsor: Optinose US Inc.

Sex: All

Age: 12 - 17

Code: NCT06850805

Phase 3, Recruiting

Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

for
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation,
Location: Louisville KY, Saint Matthews KY, Cincinnati OH,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC

Sex: All

Age: 18+

Code: NCT04088071

Recruiting

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

for
Heart Failure
Location: Louisville KY, Indianapolis IN, Richmond IN, Marion OH,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06424288

Phase 3, Recruiting

Left vs Left Randomized Clinical Trial

for
Heart Failure, Heart Failure With Reduced Ejection Fraction,
Location: Louisville KY, Cincinnati OH, Indianapolis IN,
Sponsor: Baylor College of Medicine

Sex: All

Age: 18+

Code: NCT05650658

Recruiting

Pan-tumor MRD Study

for
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer,
Location: Louisville KY, Elizabethtown KY, Lexington KY,
Sponsor: Paradigm Health

Sex: All

Age: 18+

Code: NCT06605404

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

for
Coronary Artery Disease
Location: Louisville KY, Lexington KY, Carmel IN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399692

Phase 3, Recruiting

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Louisville KY, Indianapolis IN, Fairfield OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07365241

Phase 3, Recruiting

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

for
Heart Failure - NYHA II - IV
Location: Louisville KY, Indianapolis IN, Nashville TN,
Sponsor: Boston Scientific Corporation

Sex: All

Age: 18+

Code: NCT07069738

Recruiting

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

for
Stroke
Location: Louisville KY, Cincinnati OH, Durham NC, Baltimore MD,
Sponsor: State University of New York at Buffalo

Sex: All

Age: 18+

Code: NCT00682695

Recruiting

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

for
Coronary Artery Disease
Location: Louisville KY, Lexington KY, Carmel IN, Nashville TN,
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06399705

Phase 3, Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: New Albany IN, Lexington KY, Miamisburg OH, Columbus OH,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Phase 4, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Louisville KY, Nashville TN, Columbus OH, Chicago IL,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase 1, Recruiting

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

for
Indolent B-Cell Non-Hodgkin Lymphoma
Location: Louisville KY
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT03571568

Phase 1, Phase 2, Recruiting

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

for
Multiple Myeloma (MM)
Location: Louisville KY, Atlanta GA, Grand Rapids MI, Durham NC,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07280013

Phase 1, Recruiting

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: Louisville KY, Lexington KY, Indianapolis IN,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: Louisville KY, Chicago IL, Greenville SC, Charlotte NC,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Louisville KY, Hilliard OH, Chicago IL, Detroit MI,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Louisville KY, Cincinnati OH, Nashville TN, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06297226

Phase 2, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Louisville KY, Lexington KY, Cincinnati OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Louisville KY, Elizabethtown KY, Lexington KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting